MarketPulse

strategic shift

7 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

BayCom Faces Legal Scrutiny After Executive Exodus and Stock Plunge

Law firm investigates BayCom Corp following sudden departure of CEO, COO, CFO. Stock fell 11.11% on strategic shift away from acquisitions.
BCMLsecurities fraudstock decline
BenzingaBenzinga··Vandana Singh

CareDx Divests Lab Products Unit for $170M to Accelerate High-Growth Core Business

CareDx sells Lab Products unit to EuroBio Scientific for $170M, concentrating on faster-growing Testing Services and Digital Solutions segments amid strong 39% Q1 revenue growth.
CDNArevenue growthcapital allocation
BenzingaBenzinga··Akanksha Bakshi

Spire Divests $650M Gas Storage Assets to Reshape Portfolio Focus

Spire Inc. sells natural gas storage assets to I Squared Capital for $650M, pivoting toward regulated utilities and funding Piedmont acquisition.
SRSRJNM&Astrategic shift
GlobeNewswire Inc.GlobeNewswire Inc.··Wendel

Wendel Sets May 2026 Shareholder Meeting Amid €47B Asset Management Expansion

Wendel schedules May 2026 AGM as asset management platform grows to €47 billion, signaling strategic shift toward third-party capital.
BVVBYstrategic shiftAnnual General Meeting
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

monday.com Faces Securities Fraud Class Action Over Guidance Misses and Abandoned Revenue Goals

Pomerantz Law Firm sues monday.com over guidance misses and abandoned $1.8B revenue target. Investors have until May 11, 2026, to join class action.
MNDYsecurities fraudclass action lawsuit
BenzingaBenzinga··Vandana Singh

Duolingo Shares Tumble 24% as Company Prioritizes User Growth Over Near-Term Profits

Duolingo shares plummeted 24% after prioritizing user growth over near-term profits. Morgan Stanley downgraded the stock, citing weak forward guidance despite strong operational metrics.
DUOLguidance missearnings report
BenzingaBenzinga··Vandana Singh

Catheter Precision Exits Atherectomy Business to Concentrate on EP Platform

Catheter Precision divests atherectomy business for $15M upfront plus equity stake and royalties, refocusing on electrophysiology platform.
VTAKstrategic shiftdivestiture